ScHARRSheffield: RT @DrLauraAGray: New paper out today, mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer and adding to a growing body of literature demonstrating the appropriateness of mixture model based approaches in utility mapping.
ScHARRHEDS: RT @DrLauraAGray: New paper out today, mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer and adding to a growing body of literature demonstrating the appropriateness of mixture model based approaches in utility mapping. https
ScHARRHEDS: RT @DrLauraAGray: New paper out today, mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer and adding to a growing body of literature demonstrating the appropriateness of mixture model based approaches in utility mapping. https
ScHARRSheffield: RT @DrLauraAGray: New paper out today, mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer and adding to a growing body of literature demonstrating the appropriateness of mixture model based approaches in utility mapping.